Recently, Wang et al. identified RAS protein activator-like 1 (RASAL1) as an antitumor gene that could downregulate the expression level of SCD1 and inhibit cell proliferation in CRC via the LXRα/SREBP-1c signaling pathway [81]. Here, RASAL1 is linked to colorectal carcinoma.